Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STEL
2826
DELISTED
Stellar Bancorp
STEL
| $2.63M | ﹤0.01% |
96,284
-6,477
| -6% | -$195K |
|
2827
Inseego
INSG
$77M
| $2.62M | ﹤0.01% |
25,977
+3,158
| +14% | +$289K |
|
2828
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.15B
| $2.6M | ﹤0.01% |
+50,902
| New | +$2.6M |
|
|
TRIL
2829
DELISTED
Trillium Therapeutics Inc.
TRIL
| $2.6M | ﹤0.01% |
+267,902
| New | +$2.52M |
|
2830
V2X
VVX
$2.6B
| $2.6M | ﹤0.01% |
54,577
+86
| +0.2% | +$4.43K |
|
|
DFTX
2831
Definium Therapeutics
DFTX
$5.73B
| $2.59M | ﹤0.01% |
+50,090
| New | +$2.63M |
|
2832
Radware
RDWR
$1.23B
| $2.59M | ﹤0.01% |
84,170
+19,614
| +30% | +$565K |
|
|
FPI
2833
Farmland Partners
FPI
$433M
| $2.59M | ﹤0.01% |
214,834
-540
| -0.3% | -$6.94K |
|
2834
Willdan Group
WLDN
$1.32B
| $2.58M | ﹤0.01% |
68,670
+455
| +0.7% | +$17.6K |
|
2835
Daktronics
DAKT
$986M
| $2.56M | ﹤0.01% |
389,110
-7,731
| -2% | -$50.5K |
|
|
VNE
2836
DELISTED
Veoneer, Inc.
VNE
| $2.56M | ﹤0.01% |
111,156
+10,836
| +11% | +$258K |
|
2837
Metropolitan Bank Holding Corp
MCB
$1.17B
| $2.56M | ﹤0.01% |
42,510
+3,655
| +9% | +$222K |
|
2838
MediaAlpha
MAX
$807M
| $2.55M | ﹤0.01% |
60,668
+21,227
| +54% | +$849K |
|
2839
Tower Semiconductor
TSEM
$30B
| $2.55M | ﹤0.01% |
86,619
-2,204
| -2% | -$61.9K |
|
2840
Theravance Biopharma
TBPH
$881M
| $2.55M | ﹤0.01% |
175,359
-26,950
| -13% | -$506K |
|
|
TTCF
2841
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $2.54M | ﹤0.01% |
118,541
+106,905
| +919% | +$2.1M |
|
|
ORBC
2842
DELISTED
ORBCOMM, Inc.
ORBC
| $2.53M | ﹤0.01% |
225,320
-41,167
| -15% | -$457K |
|
2843
Syndax Pharmaceuticals
SNDX
$1.77B
| $2.52M | ﹤0.01% |
146,945
+16,430
| +13% | +$301K |
|
2844
HBT Financial
HBT
$1.35B
| $2.52M | ﹤0.01% |
144,913
-1,006
| -0.7% | -$17.9K |
|
2845
Philips
PHG
$26.7B
| $2.52M | ﹤0.01% |
61,393
+7,999
| +15% | +$370K |
|
|
GTHX
2846
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.52M | ﹤0.01% |
114,826
-15,941
| -12% | -$354K |
|
2847
Aldeyra Therapeutics
ALDX
$94.1M
| $2.52M | ﹤0.01% |
222,001
+174,647
| +369% | +$2.1M |
|
|
MCBC
2848
DELISTED
Macatawa Bank Corp
MCBC
| $2.52M | ﹤0.01% |
287,521
+6,886
| +2% | +$65.7K |
|
2849
Stereotaxis
STXS
$137M
| $2.51M | ﹤0.01% |
260,321
+119,811
| +85% | +$945K |
|
2850
Transmedics
TMDX
$3.07B
| $2.5M | ﹤0.01% |
75,282
-131,131
| -64% | -$3.63M |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.